Drug

Qsymia clinical trials

studies test it: 11
open now: 1
in phase 3: 1
first study started: 2013

Keep track of what changes. Save the Qsymia studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

Qsymia: 7

Development codes

VI-0521: 1

Studies by the year they started

11 studies that test it; most in 2014 (2)

Studies that test Qsymia, by start year
Year	Studies
2013	1
2014	2
2015	2
2019	1
2020	1
2021	1
2022	1
2025	1
2026	1

By phase

A phase 1/2 study counts in both.

Early Phase 1: 1
Phase 1: 1
Phase 2: 3
Phase 3: 1
Phase 4: 5

What it is tested for

Each study’s main condition, where its own words name it.

Obesity: 3
Pediatric Obesity: 2
Bulimia: 2
Craniopharyngioma: 1
Overweight: 1

Who runs them

Industry 3 · Other 8

University of Minnesota (2) · Mayo Clinic (2) · VIVUS LLC (2) · Seattle Children's Hospital (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · Alvogen Korea (1) · Stanford University (1) · Lindner Center of HOPE (1)

Often tested with

Tested in the same studies.

Propranolol (1) · Pindolol (1) · Dantrolene (1) · Magnesium Sulfate (1) · Caffeine (1) · Topiramate (1) · Naltrexone (1) · Mirabegron (1)

Studies

Open first, then newest update. How each study uses Qsymia is read from its arms, and is right about nine times in ten.